Skip to content

    Diabetes Health Center

    Font Size
    A
    A
    A

    Inhaled Insulin Should be Approved by FDA: Panel


    WebMD News from HealthDay

    April 2, 2014 -- An inhaled insulin product to treat type 1 and type 2 diabetes should be approved for sale in the United States, a Food and Drug Administration advisory committee said Tuesday.

    The panel of outside experts said that the product -- called Afrezza -- is not as effective as injected insulin but would be useful for some patients, The New York Times reported.

    "As an inhaled form of insulin, this represents a drug that will serve some patients that are not effectively served by currently available insulin," the committee's acting chairman Dr. Robert Smith, an endocrinologist at Brown University, said after the vote.

    The advisory panel's support for Afrezza was somewhat unexpected because an FDA staff review was critical of the product, saying it was marginally effective and possibly risky, The Times reported.

    In two previous attempts, the drug failed to win FDA approval and maker MannKind Corporation had to conduct new clinical trials.

    The FDA is not required to follow the advice of its advisory panels.

    Today on WebMD

    Diabetic tools
    Symptoms, diagnosis, treatment, and more.
    woman flexing muscles
    10 strength training exercises.
     
    Blood sugar test
    12 practical tips.
    Tom Hanks
    Stars living with type 1 or type 2.
     
    kenneth fujioka, md
    Video
    Can Vinegar Treat Diabetes
    Article
     
    Middle aged person
    Tool
    jennie brand miller
    Video
     

    Prediabetes How to Prevent Type 2 Diabetes
    Article
    type 2 diabetes
    Slideshow
     
    food fitness planner
    Tool
    feet
    Slideshow